Opioid Maintenance Therapy Abroad: What Methadone, Buprenorphine and Naltrexone Travellers Must Know

Methadone is a controlled substance in nearly every country on earth, and some ban it outright. Here is what to prepare before you cross any border on opioid maintenance therapy.

Opioid maintenance therapy abroad: what you need to know

Methadone is a Schedule I or equivalent substance in over 30 countries, yet doctors in those same countries prescribe it daily for opioid use disorder. That contradiction is the central planning problem for anyone travelling on opioid maintenance therapy (OMT).

The rules governing what you can bring, how much, and whether the destination country will continue your treatment vary sharply by jurisdiction. This article covers the key country-by-country differences and the documentation you need at every border.

Medical disclaimer: This article is for general informational purposes and does not constitute medical or legal advice. Regulations change. Verify all import requirements directly with each country's embassy or health authority before travel, and discuss your specific travel plan with your prescribing physician.

Why the same medication has different legal status everywhere

The UN 1961 Single Convention on Narcotic Drugs ^[1]classifies methadone as a Schedule I narcotic. Signatory states must control it, but each one decides how tightly. Buprenorphine falls under the 1971 Convention on Psychotropic Substances. Naltrexone, an opioid antagonist, is not a controlled substance under either convention, which makes it the easiest of the three to carry internationally.

The practical consequence: a 28-day supply of methadone that is perfectly legal to carry from one country may constitute an unapproved import in the next. The prescription status in your prescribing country is irrelevant at a foreign customs desk.

Country-by-country rules at a glance

European Union. EU member states have adopted the Schengen Convention certificate system for controlled substances. A Schengen drug certificate, issued by your prescribing country's health authority, ^[2]permits you to carry up to 30 days of controlled medication across all Schengen states without repeated customs declarations. The certificate must be in your name, list the drug by INN and quantity, and carry an official stamp. Obtaining one typically takes 5 to 10 working days, so request it at least three weeks before departure.

France, Germany, the Netherlands and Spain all have functioning methadone and buprenorphine dispensing programmes. If your stay exceeds 30 days, contact the national health authority in the destination country before travel to arrange continuation of treatment. Germany requires registration with a local addiction medicine physician (Suchtmediziner) for prescriptions beyond the import window.

Japan. Japanese law prohibits methadone maintenance therapy. Methadone is registered in Japan only for palliative-care pain management, not for opioid use disorder. Buprenorphine is available for inpatient heroin detoxification but not for long-term maintenance. A traveller arriving in Japan on methadone or buprenorphine maintenance will not be able to obtain continuation dosing locally, even with a Yakkan Shoumei (Yunyu Kakunin-sho) personal-import certificate — the certificate authorises possession of the medicine you brought, but the underlying maintenance treatment modality is not lawful in Japan. Plan transitions off MAT before travel or accept that maintenance care is unavailable for the duration of the trip.

Thailand. Methadone is a Category II narcotic under Thailand's Narcotics Act. Importing it requires a prior import permit from the Food and Drug Administration (FDA Thailand) and a letter from a Thai-registered physician confirming medical necessity. The 30-day import cap applies. Government methadone maintenance clinics operate in major cities including Bangkok, Chiang Mai and Chon Buri, but access as a foreign national requires documented OMT history and is not guaranteed.

Gulf states and high-risk jurisdictions. The UAE, Saudi Arabia, Qatar, and Kuwait all classify methadone and buprenorphine as controlled narcotics requiring advance approval before import. In the UAE, that approval now comes from the Emirates Drug Establishment (EDE) at ede.gov.ae (the service moved from the Ministry of Health and Prevention on 29 December 2025). In practice, approval for opioid maintenance medications is rarely granted to short-term visitors. For trips longer than a few days, plan supply that covers the full trip with documentation rather than relying on local continuation.

United States. In the US, methadone for opioid use disorder can only be dispensed through SAMHSA-accredited and DEA-certified opioid treatment programmes (OTPs), not community pharmacies. If you are arriving in the US on methadone, your home programme must arrange guest dosing with a US OTP in advance — this is administered as a face-to-face daily visit until take-home doses are approved. Buprenorphine is more flexible: the Mainstreaming Addiction Treatment (MAT) Act eliminated the federal X-waiver requirement on 29 December 2022, so any practitioner with a current DEA registration that includes Schedule III authority can now prescribe buprenorphine for OUD without a separate waiver and without patient caps, and the prescription can be filled at a regular pharmacy.

Australia. Australia's Therapeutic Goods Administration (TGA) requires a Therapeutic Goods (Controlled Substances) permit to import Schedule 8 substances^[6] such as methadone and buprenorphine. Apply via the TGA website. Processing takes up to 10 business days. Australia has established pharmacotherapy programmes in all states and territories; continuation dosing through a local clinic is possible but requires advance coordination with the receiving prescriber, usually through your home treatment provider.

The documentation stack every OMT traveller needs

Understanding the medication import rules for each country you will visit is the single most important pre-travel task. Every country on this list has different documentary requirements, and the following documents cover the core bases.

A letter from your prescribing physician. This should state your diagnosis, the INN of the medication, daily dose, and the clinical necessity of uninterrupted supply. Ask for it on headed paper with a direct contact number for the prescriber.

Original pharmacy labels, unaltered. Keep medication in the original dispensed container. Decanted or relabelled packaging raises immediate red flags at border control.

Country-specific import permits. Schengen certificate for EU travel, Yakkan Shoumei for Japan, TGA permit for Australia, and FDA Thailand authorisation for Thailand. Every one of these takes time to obtain. Start the application process at minimum six weeks before your flight.

Storing these documents in your Nomedic medical record as part of an International Patient Summary means the key clinical data is available in a standardised, multilingual format at any border or clinic. A customs officer or emergency physician can access your medication history without language being a barrier.

Naltrexone: the easiest of the three, but not risk-free

Naltrexone is not a controlled substance under any UN drug convention and is not scheduled in most countries. The extended-release injectable form (Vivitrol) is subject to cold-chain storage requirements^[7] and cannot be carried in standard luggage without validated cold packaging. Oral naltrexone is stable at room temperature, but even this requires a physician's letter to avoid questions at customs about why you carry an opioid antagonist.

The clinical risk with naltrexone travel is interruption of treatment. Missing doses in a new time zone, jet lag, or supply disruption can destabilise recovery. Identify a local pharmacy that stocks the formulation you take before you arrive, not after.

Practical steps before you book

Confirm destination legality. Contact the embassy or consulate of every country you will visit and ask specifically about your medication by its INN. Do not rely on internet forum posts.

Apply for permits early. Six weeks is the minimum; eight weeks is safer for Japan, Gulf states, and Australia. Late applications may not be processed before departure.

Arrange guest dosing before you leave. For methadone, your prescribing programme must formally contact an approved clinic at your destination. Do not assume a clinic will accept you on arrival without pre-arrangement.

Carry more than you think you need. Flight cancellations, border delays, and quarantine scenarios can extend a trip unexpectedly. A buffer of 5 to 7 extra days of medication, where the import cap permits, reduces exposure to supply gaps.

Get your IPS updated. An International Patient Summary containing your current medications, diagnoses, and allergies gives any foreign clinician the context they need to continue your care. Create or update yours through Nomedic before you fly.

Travel insurance and OMT

Most standard travel insurance policies treat opioid use disorder as a pre-existing condition that requires disclosure^[8]. Failing to disclose it can void the entire policy, not just the OMT-related claims. Specialist medical travel insurers who accept disclosed OMT exist; your prescribing clinic or addiction medicine team may be able to refer you to one.

Emergency medical evacuation cover is especially relevant. If you cannot obtain continuation dosing at your destination and experience a medical crisis, evacuation to a country where your treatment programme can be resumed may be necessary. Confirm your policy covers evacuation for this scenario explicitly, not just physical trauma.

Frequently asked questions

Can I carry methadone on a plane internationally?

You can carry methadone on international flights in most countries, but you need prior authorisation from the destination country's health authority. The process varies: EU countries use a Schengen certificate, Japan requires a Yakkan Shoumei, and Australia requires a TGA permit. Start applications at least six weeks before travel. Some countries, particularly in the Gulf region, do not permit import under any circumstances.

What happens if my methadone is confiscated at the border?

Confiscation without prior approval is possible, particularly if documentation is incomplete. In some jurisdictions you may also face detention and criminal charges. If confiscation occurs, contact your country's consulate or embassy immediately. Carry a direct contact number for your prescribing programme so local authorities can verify your treatment status.

Is buprenorphine easier to travel with than methadone?

Buprenorphine is generally more portable because it can be dispensed at retail pharmacies in many countries, unlike methadone which often requires daily clinic attendance. However, it is still a controlled substance in most jurisdictions and requires a physician's letter and, in some countries, an import permit. Japan does not currently approve buprenorphine-naloxone as an opioid maintenance therapy, which creates a supply gap for visitors.

Do I need a special permit to carry naltrexone abroad?

Oral naltrexone is not a controlled substance under UN conventions and does not require an import permit in most countries. You should still carry a physician's letter explaining the clinical necessity. The extended-release injectable formulation requires cold-chain transport and additional planning regardless of destination.

Can I get methadone or buprenorphine at a local clinic while travelling?

In some countries, yes. The EU, Australia, and the US all have formal pharmacotherapy programmes that can provide guest dosing, but this requires your home programme to arrange the transfer in advance. Arriving at a clinic without pre-arrangement will usually result in a refusal. Countries with no OMT infrastructure, including several Gulf states and parts of Southeast Asia, cannot provide continuation dosing at all.

Does travel insurance cover opioid maintenance therapy abroad?

It depends on the policy. You must disclose opioid use disorder as a pre-existing condition when purchasing travel insurance; failing to do so can void the entire policy. Some specialist insurers offer cover that includes OMT-related care. Confirm that your policy explicitly covers medical evacuation if continuation dosing cannot be obtained at your destination.